Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo therapy helps stroke survivors walk better

NCT ID NCT07338032

Symptom relief Sponsor: University of Lahore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding task-specific training to standard physical therapy helps people who had a stroke 2-6 months ago improve ankle strength and walking. 66 participants were split into two groups: one received the combined therapy, the other standard therapy alone, for 8 weeks. The goal was to see if the extra training leads to better ankle control and safer walking.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Jun 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Onset of stroke 2-6 months before study enrollment (Van Criekinge et al., 2022). * Ability to walk with or without an assistive device (Khallaf, 2020). * Presence of a minimum of 8-10 Degree of ankle plantarflexion-dorsiflexion range * Ability to follow a three-step command, MMSE 24 (Srivastava et al., 2024). * Spasticity of plantarflexers 1 or 1+ (Abd Elsabour et al., 2025). * Not participating in any other form of physical rehabilitation. No lumber radiculopathy (Srivastava et al., 2024). Exclusion Criteria: * Uncorrected vision and hearing loss or sensory impairment (Van Criekinge et al., 2022). * Unilateral or Visual neglect (Van Criekinge et al., 2022). * Sensory or global aphasia (Khallaf, 2020). * Pain or musculoskeletal or any other neurological disorder (Srivastava et al., 2024). * Carcinoma (Srivastava et al., 2024).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke Subacute stroke

Contacts and locations

Locations

  • The University of Lahore Teaching Hospital

    Lahore, 54590, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.